- Home
- MYNZ vs SSY Comparison
MYNZ vs SSY Comparison
Compare MYNZ & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- SSY
- Stock Information
- Founded
- MYNZ 2021
- SSY 1959
- Country
- MYNZ Germany
- SSY United States
- Employees
- MYNZ N/A
- SSY N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- MYNZ Health Care
- SSY Health Care
- Exchange
- MYNZ Nasdaq
- SSY Nasdaq
- Market Cap
- MYNZ 6.1M
- SSY 5.7M
- IPO Year
- MYNZ 2021
- SSY N/A
- Fundamental
- Price
- MYNZ $0.24
- SSY $0.80
- Analyst Decision
- MYNZ Buy
- SSY
- Analyst Count
- MYNZ 2
- SSY 0
- Target Price
- MYNZ $3.00
- SSY N/A
- AVG Volume (30 Days)
- MYNZ 5.2M
- SSY 8.3K
- Earning Date
- MYNZ 11-26-2024
- SSY 11-12-2024
- Dividend Yield
- MYNZ N/A
- SSY N/A
- EPS Growth
- MYNZ N/A
- SSY N/A
- EPS
- MYNZ N/A
- SSY N/A
- Revenue
- MYNZ $917,203.00
- SSY $31,808,000.00
- Revenue This Year
- MYNZ $36.69
- SSY N/A
- Revenue Next Year
- MYNZ $91.67
- SSY N/A
- P/E Ratio
- MYNZ N/A
- SSY N/A
- Revenue Growth
- MYNZ 16.23
- SSY N/A
- 52 Week Low
- MYNZ $0.19
- SSY $0.53
- 52 Week High
- MYNZ $1.79
- SSY $1.05
- Technical
- Relative Strength Index (RSI)
- MYNZ 45.71
- SSY 45.98
- Support Level
- MYNZ $0.22
- SSY $0.79
- Resistance Level
- MYNZ $0.36
- SSY $0.86
- Average True Range (ATR)
- MYNZ 0.04
- SSY 0.04
- MACD
- MYNZ 0.00
- SSY -0.01
- Stochastic Oscillator
- MYNZ 18.59
- SSY 8.75
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.